[
  {
    "ts": null,
    "headline": "Boston Scientific Breaks Out As One Key Product Delivers 117% Growth",
    "summary": "Boston Scientific stock broke out Wednesday, helped by a strong second-quarter report on the back of its high-profile cardiovascular segment.",
    "url": "https://finnhub.io/api/news?id=bdfbf5503caad7260ddaca29700469f96b97533360a67fb5d19a3d6399517fbb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753301579,
      "headline": "Boston Scientific Breaks Out As One Key Product Delivers 117% Growth",
      "id": 136062407,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific stock broke out Wednesday, helped by a strong second-quarter report on the back of its high-profile cardiovascular segment.",
      "url": "https://finnhub.io/api/news?id=bdfbf5503caad7260ddaca29700469f96b97533360a67fb5d19a3d6399517fbb"
    }
  },
  {
    "ts": null,
    "headline": "Why Boston Scientific (BSX) Stock Is Up Today",
    "summary": "Shares of medical device company Boston Scientific (NYSE:BSX) jumped 4.2% in the afternoon session after the company reported second-quarter financial results that surpassed Wall Street expectations and raised its full-year guidance. Boston Scientific announced net sales of $5.06 billion for the quarter, a significant 22.8% increase from the same period last year. This figure comfortably beat analysts' revenue forecasts of around $4.89 billion. The company's adjusted earnings per share (EPS) cam",
    "url": "https://finnhub.io/api/news?id=dbeaa58e6ed7504fc3129d8a5632c940920ce3f980605defecb1ff64a6e50c3f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753291856,
      "headline": "Why Boston Scientific (BSX) Stock Is Up Today",
      "id": 136062408,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Shares of medical device company Boston Scientific (NYSE:BSX) jumped 4.2% in the afternoon session after the company reported second-quarter financial results that surpassed Wall Street expectations and raised its full-year guidance. Boston Scientific announced net sales of $5.06 billion for the quarter, a significant 22.8% increase from the same period last year. This figure comfortably beat analysts' revenue forecasts of around $4.89 billion. The company's adjusted earnings per share (EPS) cam",
      "url": "https://finnhub.io/api/news?id=dbeaa58e6ed7504fc3129d8a5632c940920ce3f980605defecb1ff64a6e50c3f"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific lifts 2025 outlook following 29% Q2 cardiovascular profit rise",
    "summary": "Boston Scientific reported Q2 2025 sales of over $5bn, a 22.8% rise on Q2 2024, besting previous growth estimates of 19.5% at the high end.",
    "url": "https://finnhub.io/api/news?id=2a8bfe7c55f67cfd3e8ecf5160b67b133c6b98cb07baee40ad0bcec1f992e735",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753291314,
      "headline": "Boston Scientific lifts 2025 outlook following 29% Q2 cardiovascular profit rise",
      "id": 136062409,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific reported Q2 2025 sales of over $5bn, a 22.8% rise on Q2 2024, besting previous growth estimates of 19.5% at the high end.",
      "url": "https://finnhub.io/api/news?id=2a8bfe7c55f67cfd3e8ecf5160b67b133c6b98cb07baee40ad0bcec1f992e735"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
    "summary": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=1114af7b29ab050655b3f45ce88701141887d48e2ddf2d67a0a486c987d277b6",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753288500,
      "headline": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
      "id": 136070907,
      "image": "",
      "related": "BSX",
      "source": "MarketWatch",
      "summary": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=1114af7b29ab050655b3f45ce88701141887d48e2ddf2d67a0a486c987d277b6"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Beats on Q2 Earnings, Raises 2025 View, Stock Up",
    "summary": "BSX beats Q2 estimates, raises full-year outlook as Cardiovascular sales surge and global revenues climb 22.8%.",
    "url": "https://finnhub.io/api/news?id=708602c3c7a3e964eea887b9429f5f5c594e9d57896bcccca4727fdf5c4e9610",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753286340,
      "headline": "Boston Scientific Beats on Q2 Earnings, Raises 2025 View, Stock Up",
      "id": 136062410,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "BSX beats Q2 estimates, raises full-year outlook as Cardiovascular sales surge and global revenues climb 22.8%.",
      "url": "https://finnhub.io/api/news?id=708602c3c7a3e964eea887b9429f5f5c594e9d57896bcccca4727fdf5c4e9610"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Raises Full-Year Outlook as Second-Quarter Results Beat Estimates",
    "summary": "Boston Scientific (BSX) lifted its full-year outlook on Wednesday as the medical device manufacturer",
    "url": "https://finnhub.io/api/news?id=bdca10ba0302a8023b68703bd5707213001559bde759a923051a314adc86ba79",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753280736,
      "headline": "Boston Scientific Raises Full-Year Outlook as Second-Quarter Results Beat Estimates",
      "id": 136062411,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific (BSX) lifted its full-year outlook on Wednesday as the medical device manufacturer",
      "url": "https://finnhub.io/api/news?id=bdca10ba0302a8023b68703bd5707213001559bde759a923051a314adc86ba79"
    }
  },
  {
    "ts": null,
    "headline": "Thermo Fisher Q2 Earnings & Revenues Beat, Stock Up in Pre-Market",
    "summary": "TMO tops Q2 estimates as new product launches and solid segment growth fuel revenue gains despite margin pressure.",
    "url": "https://finnhub.io/api/news?id=4cd4345523b139e488a1e38e73fcfb5a4289b993f6599034717410031f20eefb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753279740,
      "headline": "Thermo Fisher Q2 Earnings & Revenues Beat, Stock Up in Pre-Market",
      "id": 136062412,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "TMO tops Q2 estimates as new product launches and solid segment growth fuel revenue gains despite margin pressure.",
      "url": "https://finnhub.io/api/news?id=4cd4345523b139e488a1e38e73fcfb5a4289b993f6599034717410031f20eefb"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific (BSX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates",
    "summary": "Although the revenue and EPS for Boston Scientific (BSX) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
    "url": "https://finnhub.io/api/news?id=3610c6a89993f6cd56447c7ff0b35833ea53a9402636194c39e51dfb4191f44e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753277404,
      "headline": "Boston Scientific (BSX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates",
      "id": 136062413,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Although the revenue and EPS for Boston Scientific (BSX) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
      "url": "https://finnhub.io/api/news?id=3610c6a89993f6cd56447c7ff0b35833ea53a9402636194c39e51dfb4191f44e"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Eyes Breakout On Strong Second Quarter, Guidance",
    "summary": "Boston Scientific stock jumped early Wednesday on a strong second-quarter report and guidance for the full year.",
    "url": "https://finnhub.io/api/news?id=c24f9ef0f57b51c17237f08b0cd1c05334651d6dbb8ed60d15d8fb841c00e39f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753274836,
      "headline": "Boston Scientific Eyes Breakout On Strong Second Quarter, Guidance",
      "id": 136044320,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific stock jumped early Wednesday on a strong second-quarter report and guidance for the full year.",
      "url": "https://finnhub.io/api/news?id=c24f9ef0f57b51c17237f08b0cd1c05334651d6dbb8ed60d15d8fb841c00e39f"
    }
  },
  {
    "ts": null,
    "headline": "ISRG Stock Gains on Q2 Earnings & Sales Beat, Gross Margin Contracts",
    "summary": "Intuitive Surgical's second-quarter results reflect a healthy demand for procedures on higher system utilization. However, tariffs lead to a decline in the gross margin outlook.",
    "url": "https://finnhub.io/api/news?id=ddd5265487b919e5c7fb94085afff076c657cadae950a8feb02e586adbca344e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753274100,
      "headline": "ISRG Stock Gains on Q2 Earnings & Sales Beat, Gross Margin Contracts",
      "id": 136044266,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Intuitive Surgical's second-quarter results reflect a healthy demand for procedures on higher system utilization. However, tariffs lead to a decline in the gross margin outlook.",
      "url": "https://finnhub.io/api/news?id=ddd5265487b919e5c7fb94085afff076c657cadae950a8feb02e586adbca344e"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Corporation (BSX) Q2 2025 Earnings Call Transcript",
    "summary": "Boston Scientific Corporation (NYSE:BSX) Q2 2025 Earnings Conference Call July 23, 2025 8:00 AM ETCompany ParticipantsJonathan R.",
    "url": "https://finnhub.io/api/news?id=9bf377a017105fcbad8955fdd6ea70400f2c8c4492fec0d9c7368cc0a676e9ef",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753272632,
      "headline": "Boston Scientific Corporation (BSX) Q2 2025 Earnings Call Transcript",
      "id": 136045687,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "BSX",
      "source": "SeekingAlpha",
      "summary": "Boston Scientific Corporation (NYSE:BSX) Q2 2025 Earnings Conference Call July 23, 2025 8:00 AM ETCompany ParticipantsJonathan R.",
      "url": "https://finnhub.io/api/news?id=9bf377a017105fcbad8955fdd6ea70400f2c8c4492fec0d9c7368cc0a676e9ef"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific lifts annual profit view on steady heart devices demand",
    "summary": "Boston Scientific raised its annual profit forecast on Wednesday, after strong demand for its heart devices helped the U.S. medical device maker beat second-quarter profit estimates. Shares of the Massachusetts-based company rose 2.3% in premarket trading following the results. A rise in surgical procedures has benefited medical device manufacturers such as Boston Scientific, as it boosted sales and helped offset broader concerns about healthcare spending pressures.",
    "url": "https://finnhub.io/api/news?id=bf921fe50832e061b379f70327677b999e0b57c5b094aa8df7459fb211d21e2a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753271919,
      "headline": "Boston Scientific lifts annual profit view on steady heart devices demand",
      "id": 136044322,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific raised its annual profit forecast on Wednesday, after strong demand for its heart devices helped the U.S. medical device maker beat second-quarter profit estimates. Shares of the Massachusetts-based company rose 2.3% in premarket trading following the results. A rise in surgical procedures has benefited medical device manufacturers such as Boston Scientific, as it boosted sales and helped offset broader concerns about healthcare spending pressures.",
      "url": "https://finnhub.io/api/news?id=bf921fe50832e061b379f70327677b999e0b57c5b094aa8df7459fb211d21e2a"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific halves expected tariff hit",
    "summary": "The company now expects a tariff charge of $100 million this year, down from a $200 million impact forecast on the company’s first-quarter earnings call.",
    "url": "https://finnhub.io/api/news?id=2008b6e689bde76971d9cc172ef714ded12842fa50441d35af52ce9e78fd8f05",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753271640,
      "headline": "Boston Scientific halves expected tariff hit",
      "id": 136062414,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "The company now expects a tariff charge of $100 million this year, down from a $200 million impact forecast on the company’s first-quarter earnings call.",
      "url": "https://finnhub.io/api/news?id=2008b6e689bde76971d9cc172ef714ded12842fa50441d35af52ce9e78fd8f05"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific (BSX) Q2 Earnings and Revenues Surpass Estimates",
    "summary": "Boston Scientific (BSX) delivered earnings and revenue surprises of +4.17% and +3.48%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=61332c4f306ccf509d0751750bd9f96cc6a892288e74017c1b6056d2c9d20beb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753270801,
      "headline": "Boston Scientific (BSX) Q2 Earnings and Revenues Surpass Estimates",
      "id": 136044323,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific (BSX) delivered earnings and revenue surprises of +4.17% and +3.48%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=61332c4f306ccf509d0751750bd9f96cc6a892288e74017c1b6056d2c9d20beb"
    }
  },
  {
    "ts": null,
    "headline": "Stocks Advance Pre-Bell as Trump Announces New Trade Deals; Alphabet, Tesla Earnings on Deck",
    "summary": "The main US stock measures were tracking in the green in Wednesday's premarket activity after Presid",
    "url": "https://finnhub.io/api/news?id=4c84a807c1af7fc46757501ada1c9dc25cc092fa3db3be8dfab47e93b4a40704",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753269821,
      "headline": "Stocks Advance Pre-Bell as Trump Announces New Trade Deals; Alphabet, Tesla Earnings on Deck",
      "id": 136044123,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "The main US stock measures were tracking in the green in Wednesday's premarket activity after Presid",
      "url": "https://finnhub.io/api/news?id=4c84a807c1af7fc46757501ada1c9dc25cc092fa3db3be8dfab47e93b4a40704"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific trumps top and bottom-line forecasts, issues upbeat 2025 guide",
    "summary": "Investing.com -- Boston Scientific (NYSE:BSX) posted second-quarter results that topped expectations, driven by strong organic growth and solid performance across key regions.",
    "url": "https://finnhub.io/api/news?id=b8586640bce546d45665ea0e1b2531f4013b6152badcc047e09f6641abec18c0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753269060,
      "headline": "Boston Scientific trumps top and bottom-line forecasts, issues upbeat 2025 guide",
      "id": 136044325,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Investing.com -- Boston Scientific (NYSE:BSX) posted second-quarter results that topped expectations, driven by strong organic growth and solid performance across key regions.",
      "url": "https://finnhub.io/api/news?id=b8586640bce546d45665ea0e1b2531f4013b6152badcc047e09f6641abec18c0"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific: Q2 Earnings Snapshot",
    "summary": "The results beat Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for earnings of 72 cents per share. The medical device manufacturer posted revenue of $5.06 billion in the period, also exceeding Street forecasts.",
    "url": "https://finnhub.io/api/news?id=a7e9f9729971c2214af31d7c53343aae286ca486e4bacc4e93b260d9508878dd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753267256,
      "headline": "Boston Scientific: Q2 Earnings Snapshot",
      "id": 136044326,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "The results beat Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for earnings of 72 cents per share. The medical device manufacturer posted revenue of $5.06 billion in the period, also exceeding Street forecasts.",
      "url": "https://finnhub.io/api/news?id=a7e9f9729971c2214af31d7c53343aae286ca486e4bacc4e93b260d9508878dd"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific (NYSE:BSX) Reports Bullish Q2, Guides for Strong Sales Next Quarter",
    "summary": "Medical device company Boston Scientific (NYSE:BSX) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 22.8% year on year to $5.06 billion. Guidance for next quarter’s revenue was optimistic at $4.97 billion at the midpoint, 2.2% above analysts’ estimates. Its non-GAAP profit of $0.75 per share was 3.4% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=908b6158f1d59d61b71f66e40263e2faec6227933c3bcf213b5ee49ac73793b5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753267098,
      "headline": "Boston Scientific (NYSE:BSX) Reports Bullish Q2, Guides for Strong Sales Next Quarter",
      "id": 136044327,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Medical device company Boston Scientific (NYSE:BSX) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 22.8% year on year to $5.06 billion. Guidance for next quarter’s revenue was optimistic at $4.97 billion at the midpoint, 2.2% above analysts’ estimates. Its non-GAAP profit of $0.75 per share was 3.4% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=908b6158f1d59d61b71f66e40263e2faec6227933c3bcf213b5ee49ac73793b5"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific announces results for second quarter 2025",
    "summary": "Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.061 billion during the second quarter of 2025, growing 22.8 percent on a reported basis, 21.6 percent on an operational1 basis and 17.4 percent on an organic2 basis, all compared to the prior year period. The company reported GAAP net income attributable to Boston Scientific common stockholders of $797 million or $0.53 per share (EPS), compared to $324 million or $0.22 per share a year ago, and achieved adjusted3 EPS of $0.75 fo",
    "url": "https://finnhub.io/api/news?id=a82607584213ffb2f29aad70421943847e07d00778297d25cb1c96e19187a955",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753266600,
      "headline": "Boston Scientific announces results for second quarter 2025",
      "id": 136044328,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.061 billion during the second quarter of 2025, growing 22.8 percent on a reported basis, 21.6 percent on an operational1 basis and 17.4 percent on an organic2 basis, all compared to the prior year period. The company reported GAAP net income attributable to Boston Scientific common stockholders of $797 million or $0.53 per share (EPS), compared to $324 million or $0.22 per share a year ago, and achieved adjusted3 EPS of $0.75 fo",
      "url": "https://finnhub.io/api/news?id=a82607584213ffb2f29aad70421943847e07d00778297d25cb1c96e19187a955"
    }
  },
  {
    "ts": null,
    "headline": "[Latest] Global Inferior Vena Cava IVC Filter Market Size/Share Worth USD 2,094.10 Million by 2034 at a 8.88% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT)",
    "summary": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Inferior Vena Cava IVC Filter Market size & share revenue was valued at approximately USD 895.82 Million in 2024 and is expected to reach USD 974.16 Million in 2025 and is expected to reach around USD 2,094.10 Million by 2034, at a CAGR of 8.88% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Abbott, B.",
    "url": "https://finnhub.io/api/news?id=aef0a10f3f44579c2de3768d1afc9546fddb66fcce8d37d782b537a1fddc9e35",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753259400,
      "headline": "[Latest] Global Inferior Vena Cava IVC Filter Market Size/Share Worth USD 2,094.10 Million by 2034 at a 8.88% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT)",
      "id": 136039638,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Inferior Vena Cava IVC Filter Market size & share revenue was valued at approximately USD 895.82 Million in 2024 and is expected to reach USD 974.16 Million in 2025 and is expected to reach around USD 2,094.10 Million by 2034, at a CAGR of 8.88% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Abbott, B.",
      "url": "https://finnhub.io/api/news?id=aef0a10f3f44579c2de3768d1afc9546fddb66fcce8d37d782b537a1fddc9e35"
    }
  },
  {
    "ts": null,
    "headline": "Alphabet and Tesla Earnings, Home Sales and More: Still to Come This Week",
    "summary": "Earnings season rolls on, with the first two of the Magnificent Seven, Tesla and Alphabet, set to report later Wednesday. Plus, new economic data will shed light on how tariffs are affecting consumer and business spending, while investors watch for further trade-deal announcements.",
    "url": "https://finnhub.io/api/news?id=75785aa8afa22e6976704a4ba4cd313a40762c6de9c9ccf49c4d45bc5d6f1d29",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753255002,
      "headline": "Alphabet and Tesla Earnings, Home Sales and More: Still to Come This Week",
      "id": 136039613,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Earnings season rolls on, with the first two of the Magnificent Seven, Tesla and Alphabet, set to report later Wednesday. Plus, new economic data will shed light on how tariffs are affecting consumer and business spending, while investors watch for further trade-deal announcements.",
      "url": "https://finnhub.io/api/news?id=75785aa8afa22e6976704a4ba4cd313a40762c6de9c9ccf49c4d45bc5d6f1d29"
    }
  },
  {
    "ts": null,
    "headline": "Baron Health Care Fund Q2 2025 Shareholder Letter",
    "summary": "Baron Health Care Fund Q2 2025 Shareholder Letter",
    "url": "https://finnhub.io/api/news?id=2a38b587e95b4466e191dc0d0785bc071c09227e082ab14e1840dabaef7d2da8",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753254780,
      "headline": "Baron Health Care Fund Q2 2025 Shareholder Letter",
      "id": 136040471,
      "image": "",
      "related": "BSX",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=2a38b587e95b4466e191dc0d0785bc071c09227e082ab14e1840dabaef7d2da8"
    }
  },
  {
    "ts": null,
    "headline": "Boston Sci 2Q Net Surges, Company Boosts '25 EPS View on Cardiology Demand",
    "summary": "Boston Sci 2Q Net Surges, Company Boosts '25 EPS View on Cardiology Demand",
    "url": "https://finnhub.io/api/news?id=ba80c3919c7087d466cc065bda9b15b1f03564047222839133b820189af4190d",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753254060,
      "headline": "Boston Sci 2Q Net Surges, Company Boosts '25 EPS View on Cardiology Demand",
      "id": 136048030,
      "image": "",
      "related": "BSX",
      "source": "MarketWatch",
      "summary": "Boston Sci 2Q Net Surges, Company Boosts '25 EPS View on Cardiology Demand",
      "url": "https://finnhub.io/api/news?id=ba80c3919c7087d466cc065bda9b15b1f03564047222839133b820189af4190d"
    }
  }
]